Allstate Stock Slides as Argus Cuts Rating to Hold on Valuation
A market report highlighted an Argus downgrade of Allstate shares from Buy to Hold after the stock surpassed its $238 price target and traded around $257.62. The move reflects concerns that the insurer is fully valued, even though Q2 2026 results beat expectations and guidance supported the earnings story. Shares slipped about 1.6% in pre-open trading.